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To achieve acceptance in this interdisciplinary scientific era, 
any promising new technology must first undergo extensive 
experimental investigation and clinical trial verification. 
There often follow periods of critical reexamination of 
operative mechanisms, as well as optimal application. Myo-
cardial contrast echocardiography is no exception. This 
procedure grew out of substantial clinical experience; its 
primary aim is quantitation of the degree and spatial distri-
bution of myocardial perfusion, supplementing echocardio-
graphic measurements of regional cardiac function. A dec-
ade of intensive animal research is highlighted in several 
recent reviews (1-4). Clinical demonstrations point to these 
features of up to date myocardial contrast echocardiog-
raphy: 1) safety and minimal effects on hemodynamics or 
cardiac function; 2) favorable logistics for serial studies (for 
example, in the catheterization laboratory or during cardiac 
surgery); and 3) capability of characterizing regional myo-
cardial perfusion deficiencies and evaluating the effective-
ness of interventions. 
General state of the art. Significant advances in echocar-
diographic contrast agents have been reported recently (5,6). 
Thus, Feinstein et al. (5) summarized a multicenter clinical 
evaluation of the safety and applicability of a sonicated 
albumin agent, featuring controlled microbubbles <5 /Lm in 
diameter. Several other groups (6-11) contributed to mount-
ing expectations that there will soon be available essentially 
inert echo cardiographic contrast media that can be safely 
and effectively administered in the aorta and within coronary 
arteries for myocardial perfusion measurements. Recent 
studies demonstrated attractive potentials for defining myo-
cardial perfusion territories (12), studying the physiologic 
significance of coronary stenoses (13), evaluating coronary 
collateral flow (14) and possibly differentiating endocardial 
versus epicardial perfusion (15). There remains a need for 
additional evidence of reproducibility, satisfactory modes of 
analysis and validity of resulting data. 
In light of the demonstration of efficient transpulmonary 
delivery of the new agents and enhanced ultrasound imaging 
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of the left ventricular chamber (5-9), attention is now 
focused on eventual intravenous echocardiographic contrast 
quantitation of myocardial perfusion and ischemic zone 
delineation. Such measurements have yet to be demon-
strated, and one should understand that the improved echo-
cardiographic contrast techniques are still experimental and 
require further corroboration. The crucial development of a 
"noninvasive" intravenous method of myocardial contrast 
echocardiography calls for understanding the processes mi-
crobubbles undergo as they pass from the right side of the 
heart toward the coronary artery. In parallel, consideration 
is given to advanced ultrasound systems specially dedicated 
to the needs of myocardial contrast echocardiography for 
measurement of absolute myocardial blood flow (16). 
Application of myocardial contrast echocardiography to 
study physiology. Efforts have also been made to utilize the 
new technique to extend insights into the pathophysiology of 
ischemia. Kaul and his colleagues (1-3) have been in the 
forefront of systematizing myocardial contrast echocardio-
graphic studies of regional perfusion, as well as quantitating 
risk zones in the presence of coronary occlusion, supple-
menting measurement of regional wall motion. Indirectly, 
yet more readily than other current in vivo approaches, 
echocardiographic contrast opacification of regional myocar-
dium characterizes the configuration and state of coronary 
vessels and the microcirculatory distribution. Angiographic 
evaluation of coronary collateral flow is often inadequate, 
and measurements of regional function may not fully reflect 
the collateral circulation. Kaul et al. (14) recently paved the 
way for the use of myocardial contrast echocardiography for 
the study of coronary collateral flow. The same group is also 
involved in developing applications in the setting of coronary 
bypass surgery (17). 
The present study. In this issue of the Journal, Kaul et al. 
(18) report on an experimental demonstration of changes in 
the perfusion zone as a function of coronary blood inflow 
and collateral compensation. The study was carried out in 
open chest dogs, with the left circumflex coronary artery 
cannulated and receiving varying amounts of arterial blood 
flow through a roller pump. In the first series of dogs, 
myocardial blood flow delivered anterogradely into the ana-
tomically defined left circumflex myocardial zone was deter-
mined with radioactive microspheres injected directly into 
the artery. The size of the perfusion bed was measured with 
myocardial contrast two-dimensional echocardiography. In 
a second group of dogs, radioactive microspheres were 
injected into both the left circumflex coronary artery and the 
left atrium to measure the anterograde as well as total 
nutritive supply to discrete segments of the (left circumflex-
perfused) territory. In contrast to some prior assumptions of 
perfusion bed constancy, the left circumflex perfusion bed 
size decreased significantly when the anterograde myocar-
dial blood flow rate was sharply reduced (for example, to 
<33% of normal perfusion). This change in bed size oc-
curred primarily at the lateral margins of the perfusion 
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territory. At very low flow levels, there was a significant 
direct relation indicating that the lower the anterograde flow, 
the greater was the blood flow derived from remote vessels 
by means of existing collateral flow delivered primarily but 
not exclusively to the otherwise severely deficient lateral 
segments of the perfusion zone. 
Evaluation and interpretation. Although the study (18) is 
limited and variability inherent in the model or measure-
ments is reflected in the detailed segmental data in Tables I 
to 6, the conclusions regarding the effects at the margin of 
the perfusion zone during severe inflow deprivation appear 
plausible. Several points must be kept in mind. First, the 
myocardial circulation in the human differs from that in the 
dog (for example, in terms of endocardial-epicardial collat-
eral distribution). Apart from perfusion zone anatomy, cir-
culation characteristics such as vascular pressure and resis-
tance at different portions of the coronary artery tree would 
be expected to have a bearing on the heterogeneity of 
myocardial segment to segment perfusion. Similarly, pres-
sure differences and microvessel configuration surely influ-
ence the amount and direction of flow through pre-existing 
collateral vessels. The influences of coronary control mech-
anisms are obviously very complex. Conjectures about 
collateral flow potentiation seem premature, even though 
some new concepts may be forthcoming in this era of 
intravascular laser, ultrasound and other interventions. At 
this time, it seems best to point to the evident flow-induced 
perfusion zone changes without as yet anticipating quantita-
tive generalization of the observed effects. 
Implications and applications. Myocardial contrast echo-
cardiography can help characterize the significance of coro-
nary artery stenosis by measuring the perfused territory and 
myocardial blood flow and its distribution at rest or during 
increased stress. Regional and global function is derived 
simultaneously. In the absence of collateral flow compensa-
tion, significantly decreased anterograde blood supply leads 
to a reduction of the perfusion zone, whose lateral margins 
may require early treatment to maintain tissue viability and 
function. In the case of complex vessel disease, echocardio-
graphic contrast injections into severely and moderately 
obstructed coronary vessels yield information on the relative 
contributions to blood flow in central and lateral segments of 
perfusion beds. The degree of collateral flow compensation 
can be evaluated, facilitating decisions regarding optimal 
intervention. Effectiveness of the treatment can then be 
assessed with sequential myocardial contrast echocardiog-
raphy in a variety of settings. Studies might elucidate failed 
versus successful angioplasty, restenosis or potential reoc-
clusion. 
In connection with thrombolytic reperfusion, contrast 
measurement of perfusion zones and myocardial blood flow 
may yield insights into phenomena such as hyperemia and 
functional stunning. Anterograde and coronary venous in-
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tracoronary drug injections and mechanical support tech-
niques could be evaluated. Finally, in relation to alternate 
methods of perfusion measurement, myocardial contrast 
echocardiography may be advantageous in terms oflogistics, 
costs and its ability to provide sequential data defining 
physiologic states and optimal interventions. 
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